TechnipFMC PLC

FTI remains in a Stage 2 advancing regime with a clear intermediate uptrend and is currently pulling back into declining short-term EMAs while holding key support. Under the Compounders strategy, execution should be deferred until there is clear pullback acceptance around the 9-/20-day EMA and the 50-day SMA, given neutral overbought/oversold conditions and softened short-term momentum.

• ↑Q2 revenue of $2.76B, up 9% YoY; management sees $10B target by 2026.
• ↑EBITDA margin of 21.5% and free cash flow of $488M; 95% returned to shareholders.
• ↓Book-to-price indicates overvaluation relative to tangible assets.